Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Krause

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Open Forum Infectious Diseases|April 11, 2019
Plazomicin Is Active Against Metallo-β-Lactamase-Producing EnterobacteriaceaeAlisa W Serio, Tiffany Keepers, Kevin M Krause
Antimicrobial Agents and Chemotherapy|May 28, 2015
Validation of Sensititre Dry-Form Broth Microdilution Panels for Susceptibility Testing of Ceftazidime-Avibactam, a Broad-Spectrum-β-Lactamase Inhibitor CombinationRonald N Jones, Nicole M Holliday, Kevin M Krause
Open Forum Infectious Diseases|July 16, 2020
A Broken Antibiotic Market: Review of Strategies to Incentivize Drug DevelopmentSujata M Bhavnani, Kevin M Krause, Paul G Ambrose
Diagnostic Microbiology and Infectious Disease|March 1, 2011
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococciDavid J Farrell, Kevin M Krause, Bret M Benton
Ecosal Plus|November 18, 2018
Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing RejuvenationAlisa W Serio, Tiffany Keepers, Logan Andrews, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2018
<i>In Vivo</i> Efficacy of Plazomicin Alone or in Combination with Meropenem or Tigecycline against Enterobacteriaceae Isolates Exhibiting Various Resistance Mechanisms in an Immunocompetent Murine Septicemia ModelKamilia Abdelraouf, Aryun Kim, Kevin M Krause, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibioticJohanne Blais, Stacey R Lewis, Kevin M Krause, et al.
Cold Spring Harbor Perspectives in Medicine|June 3, 2016
Aminoglycosides: An OverviewKevin M Krause, Alisa W Serio, Timothy R Kane, et al.
Diagnostic Microbiology and Infectious Disease|September 18, 2010
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studiesKevin M Krause, Steven L Barriere, Michael M Kitt, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2009
Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia modelSharath S Hegde, Stacey Difuntorum, Robert Skinner, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|April 11, 2019
Plazomicin Is Active Against Metallo-β-Lactamase-Producing EnterobacteriaceaeAlisa W Serio, Tiffany Keepers, Kevin M Krause
Antimicrobial Agents and Chemotherapy|May 28, 2015
Validation of Sensititre Dry-Form Broth Microdilution Panels for Susceptibility Testing of Ceftazidime-Avibactam, a Broad-Spectrum-β-Lactamase Inhibitor CombinationRonald N Jones, Nicole M Holliday, Kevin M Krause
Open Forum Infectious Diseases|July 16, 2020
A Broken Antibiotic Market: Review of Strategies to Incentivize Drug DevelopmentSujata M Bhavnani, Kevin M Krause, Paul G Ambrose
Diagnostic Microbiology and Infectious Disease|March 1, 2011
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococciDavid J Farrell, Kevin M Krause, Bret M Benton
Ecosal Plus|November 18, 2018
Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing RejuvenationAlisa W Serio, Tiffany Keepers, Logan Andrews, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2018
<i>In Vivo</i> Efficacy of Plazomicin Alone or in Combination with Meropenem or Tigecycline against Enterobacteriaceae Isolates Exhibiting Various Resistance Mechanisms in an Immunocompetent Murine Septicemia ModelKamilia Abdelraouf, Aryun Kim, Kevin M Krause, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibioticJohanne Blais, Stacey R Lewis, Kevin M Krause, et al.
Cold Spring Harbor Perspectives in Medicine|June 3, 2016
Aminoglycosides: An OverviewKevin M Krause, Alisa W Serio, Timothy R Kane, et al.
Diagnostic Microbiology and Infectious Disease|September 18, 2010
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studiesKevin M Krause, Steven L Barriere, Michael M Kitt, et al.
The Journal of Antimicrobial Chemotherapy|January 22, 2009
Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia modelSharath S Hegde, Stacey Difuntorum, Robert Skinner, et al.
Pageof 5